摘要:
This invention relates to alkylamino and alkyl amino alkyl diarylketones of the formula
where Ar is aryl of the formula where V is hydrogen, halogen, loweralkyl, loweralkoxy, CF₃, NO₂ and u is an integer of 1 to 3; X and Y are independently CH₂-, -CF₂- or -CHF-; Z and W are independently -CH₂-, -O-, -CHOH-, or -CHF-; m, n, p, q and t are integers which are independently 0 or 1; R₁ is H or loweralkyl; R₂ and R₃ are loweralkyl; and the pharmaceutically acceptable acid addition salts thereof and where applicable the geometric and optical isomers and racemic mixtures thereof. The compounds of this invention display utility as analgesic agents and as agents for alleviating various memory dysfunctions, characterized by a decreased cholinergic function, such as Alzheimer's disease.
摘要:
The present invention provides a process for preparing a compound of formula (Vl) or a salt thereof, the process comprising: (i) reacting 4-methoxyphenyl acetone with an amine of formula (VIII) under conditions of reductive amination to produce a compound of formula (II) or a salt thereof, wherein there is no isolation of an imine intermediate formed during the reductive amination; (ii) condensing the compound (II) or the acid addition salt thereof with an α-haloketone of formula (III) to produce the compound of formula (IV); (iii) reducing the compound (IV) to a compound of formula (V); and (iv) reducing the compound (V) to the compound of formula (Vl), wherein the reduction is carried out in the presence of either (1 ) a hydrogen donating compound in the presence of a hydrogen transfer catalyst; or (2) ammonium formate using a hydrogenation catalyst, wherein: R1 and R2 are independently optionally substituted arylalkyl, and Hal is selected from chloro or bromo.
摘要:
Primary intermediates for hair coloring compositions for oxidative dyeing of hair are compounds of the formula (1): wherein R is hydrogen, hydroxy, nitro, amino, halogen, C1 to C5 alkyl or haloalkyl, C1 to C5 alkoxy, C1 to C5 hydroxyalkyl and C1 to C5 hydroxyalkoxy; Ar is an aromatic group, preferably an aromatic group selected from a furanyl, thienyl, pyridinyl, phenyl, 2,3-dihydrobenzo[1,4]dioxin-5 or 6-yl or benzo[1,3]dioxol-4 or 5-yl group; and y =1 to 3.
摘要:
A compound represented by formula (1) wherein each of ring A, ring B and ring C is independently a substituted or unsubstituted aromatic ring or a substituted or unsubstituted five or six-membered heterocycle which may be condensed with a benzene ring, when ring A, ring B and/or ring C is a substituted or unsubstituted five-membered heterocycle W1, W2 and/or W3 represents a bonding, X is D- or -NR1- (where R¿1? is hydrogen, a lower alkyl or the like), Y is hydrogen, a lower alkyl, a lower alkenyl or the like, and, for V?1 and V2¿ one is a single bond and the other is a single bond, -O- or the like, and a medicine comprising the compound.
摘要:
2-Phenoxyaniline derivatives represented by general formula (I) or pharmaceutically acceptable salts thereof, wherein R represents a hydrogen atom, an amino group, or an NHCOR group; and R represents a halogen atom, an amino group, a cyano group, a C1-6 alkyl group, a C1-3 perfluoroalkyl group, an NHCOR group, a CH2OR group, an OCH2R group, or a COR group (wherein R represents a C1-6 alkyl group; R represents a hydrogen atom or a C1-6 alkyl group; R represents a hydrogen atom, a C1-6 alkyl group, a C1-5 aminoalkyl group, a C2-7 alkoxycarbonyl group, or a carbamoyl group; and R represents a C1-6 alkyl group, or an unsubstituted or (halogen, amino, cyano, or C1-6 straight-chain or branched alkyl)-substituted C3-8 cycloalkyl group).
摘要翻译:由通式(I)表示的2-苯氧基苯胺衍生物或其药学上可接受的盐,其中R 1表示氢原子,氨基或NHCOR 3基团; R 2表示卤素原子,氨基,氰基,C 1-6烷基,C 1-3全氟烷基,NHCOR 3基,CH 2 OR 4基,OCH 2 R 5 >基或COR 6基(其中R 3表示C 1-6烷基; R 4表示氢原子或C 1-6烷基; R 5表示氢原子, C 1-6烷基,C 1-5氨基烷基,C 2-7烷氧基羰基或氨基甲酰基; R 6表示C 1-6烷基,或未取代的或(卤素,氨基,氰基或 C 1-6直链或支链烷基) - 取代的C 3-8环烷基)。
摘要:
A method is disclosed for the preparation of optically pure isomes of formeterol, especially the (R,R)- and (S,S)-isomer, by the reaction of an optically pure 4-benzyloxy-3-formamidostyrene oxide with an optically pure 4-methoxy- alpha -methyl-N-(phenylmethyl)benzeneethanamine followed by debenzylation. Useful intermediates in the process are also disclosed, as is the novel L-tartrate salt of R,R-formoterol.
摘要:
A 2-phenoxyaniline derivative represented by the formula: wherein R 1 is a hydrogen atom, an amino group or an NHCOR 3 group, R 2 is a halogen atom, an amino group, a cyano group, a C 1-6 alkyl group, a C 1-3 perfluoroalkyl group, an NHCOR 3 group, a CH 2 OR 4 group, an OCH 2 R 5 group or a COR 6 group, R 3 is a C 1-6 alkyl group, R 4 is a hydrogen atom or a C 1-6 alkyl group, R 5 is a hydrogen atom, a C 1-6 alkyl group, a C 1-5 aminoalkyl group, a C 2-7 alkoxycarbonyl group or a carbamoyl group, and R 6 is a C 1-6 alkyl group or a C 3-8 cycloalkyl group which is unsubstituted or substituted by a halogen atom, an amino group, a cyano group or a straight or branched C 1-6 alkyl group; or a pharmaceutically acceptable salt thereof.